Circuit Splits Surrounding FCA Endure Post-Takeda
When the U.S. Supreme Court denied the petition of a relator seeking review of the Fourth Circuit decision United States ex rel. Nathan v. Takeda Pharmaceuticals North America, 707 F.3d 451...To view the full article, register now.
Already a subscriber? Click here to view full article